XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Sales $ 24,092,787 $ 4,345,603
Cost of sales 15,753,616 2,649,028
Gross profit 8,339,171 1,696,575
General and Administrative Expenses:    
Accounting 463,705 341,139
Consulting 850,173 842,894
Director fees 400,000 300,000
Goodwill impairment 0 18,326,719
Legal 512,199 550,117
Marketing 734,248 578,085
Office 2,142,355 796,007
Patent fees 14,108 15,148
R&D 1,855,830 811,858
Salaries 5,712,968 6,054,962
Taxes 289,737 55,233
Depreciation & amortization 149,147 25,163
Total General and Administrative Expenses 13,124,470 28,697,325
(Loss) From Operations (4,785,299) (27,000,750)
Other Income (Expense):    
Foreign exchange (loss) (245) (476)
Interest income 811,974 518,650
Interest expense (137,308) (39,412)
Debt release 0 10,852
Total Other Income (Expense) 674,421 489,614
Net (loss) before income taxes (4,110,878) (26,511,136)
Provision for income taxes 395,166 233,304
Net (Loss (4,506,044) (26,744,440)
Foreign exchange translation 534,258 184,986
Comprehensive Income (Loss) $ (3,971,786) $ (26,559,454)
Basic (Loss) per common share $ (351.36) $ (3,523.44)
Diluted (Loss) per common share $ (351.36) $ (3,523.44)
Weighted average common shares outstanding (basic) 12,825 7,590
Weighted average common shares outstanding (diluted) 12,825 7,590